Value-based healthcare: Il nuovo approccio di AIFA alla determinazione multidimensionale del valore

In this viewpoint, we discuss the approach promoted by the Italian Drug Agency (AIFA) to the assessment of the value of new pharmaceuticals in the Italian Healthcare Service. On top of traditionally acknowledged components, such as quality adjusted life years gained and net costs, the overall value...

Descripción completa

Detalles Bibliográficos
Autores principales: Ciani, Oriana, Federici, Carlo, Fornaro, Giulia, Rognoni, Carla
Formato: Online Artículo Texto
Lenguaje:English
Publicado: AboutScience 2020
Materias:
Point of View
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9677615/
https://www.ncbi.nlm.nih.gov/pubmed/36627957
http://dx.doi.org/10.33393/grhta.2020.2102

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9677615/
https://www.ncbi.nlm.nih.gov/pubmed/36627957
http://dx.doi.org/10.33393/grhta.2020.2102

Ejemplares similares